Preoperative erectile function and the pathologic features of prostate cancer

Purpose We evaluated whether preoperative erectile function is associated with pathologic features in the patients who underwent radical prostatectomy (RP). Materials and Methods We reviewed medical records of 1,743 men who underwent RP from November 2003 through May 2012. Of these, 50 patients who had prior hormone therapy and 272 patients who had lacking data of International Index of Erectile Function-5 (IIEF-5) were excluded. Men whose IIEF-5 was in the lower 25 percentile were assigned as Low Erectile Function group and the others were assigned as Control group. We compared pathologic features using univariable and multivariable logistic regression analysis between two groups. Results A total of 1,421 patients were included in the analysis. Patients’ age was 65.8 ± 6.7 years and prostate-specific antigen (PSA) was 12.8±16.1 ng/mL. Median and low 25 percentile of IIEF-5 were 14 and 8, respectively. Low Erectile Function group (IIEF-5<8) had higher risk to have high Gleason score (≥7(4+3), odds ratio (OR) 1.642, p<0.001) and large tumor volume (≥5 mL, OR 1.292, p=0.042). Even after adjusting age, year of surgery, body mass index, Charlson comorbidity index, PSA, clinical stage and biopsy Gleason score, Low Erectile Function group still had higher risk of high Gleason score (OR 1.910, p<0.001) and large tumor volume (OR 1.390, p=0.04) by multivariable logistic regressions. Conclusions Lower erectile function before RP was associated with higher Gleason’s score and larger tumor volume in final pathology. Thus, erectile function could be a surrogate barometer for prostate cancer aggressiveness.

Saved in:
Bibliographic Details
Main Authors: Jeong,Chang Wook, Lee,Sangchul, Jeong,Seong Jin, Hong,Sung Kyu, Byun,Seok-Soo, Lee,Sang Eun
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2015
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000200265
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382015000200265
record_format ojs
spelling oai:scielo:S1677-553820150002002652015-06-01Preoperative erectile function and the pathologic features of prostate cancerJeong,Chang WookLee,SangchulJeong,Seong JinHong,Sung KyuByun,Seok-SooLee,Sang Eun Prostatic neoplasms erectile function pathology Purpose We evaluated whether preoperative erectile function is associated with pathologic features in the patients who underwent radical prostatectomy (RP). Materials and Methods We reviewed medical records of 1,743 men who underwent RP from November 2003 through May 2012. Of these, 50 patients who had prior hormone therapy and 272 patients who had lacking data of International Index of Erectile Function-5 (IIEF-5) were excluded. Men whose IIEF-5 was in the lower 25 percentile were assigned as Low Erectile Function group and the others were assigned as Control group. We compared pathologic features using univariable and multivariable logistic regression analysis between two groups. Results A total of 1,421 patients were included in the analysis. Patients’ age was 65.8 ± 6.7 years and prostate-specific antigen (PSA) was 12.8±16.1 ng/mL. Median and low 25 percentile of IIEF-5 were 14 and 8, respectively. Low Erectile Function group (IIEF-5<8) had higher risk to have high Gleason score (≥7(4+3), odds ratio (OR) 1.642, p<0.001) and large tumor volume (≥5 mL, OR 1.292, p=0.042). Even after adjusting age, year of surgery, body mass index, Charlson comorbidity index, PSA, clinical stage and biopsy Gleason score, Low Erectile Function group still had higher risk of high Gleason score (OR 1.910, p<0.001) and large tumor volume (OR 1.390, p=0.04) by multivariable logistic regressions. Conclusions Lower erectile function before RP was associated with higher Gleason’s score and larger tumor volume in final pathology. Thus, erectile function could be a surrogate barometer for prostate cancer aggressiveness. info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.41 n.2 20152015-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000200265en10.1590/S1677-5538.IBJU.2015.02.12
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Jeong,Chang Wook
Lee,Sangchul
Jeong,Seong Jin
Hong,Sung Kyu
Byun,Seok-Soo
Lee,Sang Eun
spellingShingle Jeong,Chang Wook
Lee,Sangchul
Jeong,Seong Jin
Hong,Sung Kyu
Byun,Seok-Soo
Lee,Sang Eun
Preoperative erectile function and the pathologic features of prostate cancer
author_facet Jeong,Chang Wook
Lee,Sangchul
Jeong,Seong Jin
Hong,Sung Kyu
Byun,Seok-Soo
Lee,Sang Eun
author_sort Jeong,Chang Wook
title Preoperative erectile function and the pathologic features of prostate cancer
title_short Preoperative erectile function and the pathologic features of prostate cancer
title_full Preoperative erectile function and the pathologic features of prostate cancer
title_fullStr Preoperative erectile function and the pathologic features of prostate cancer
title_full_unstemmed Preoperative erectile function and the pathologic features of prostate cancer
title_sort preoperative erectile function and the pathologic features of prostate cancer
description Purpose We evaluated whether preoperative erectile function is associated with pathologic features in the patients who underwent radical prostatectomy (RP). Materials and Methods We reviewed medical records of 1,743 men who underwent RP from November 2003 through May 2012. Of these, 50 patients who had prior hormone therapy and 272 patients who had lacking data of International Index of Erectile Function-5 (IIEF-5) were excluded. Men whose IIEF-5 was in the lower 25 percentile were assigned as Low Erectile Function group and the others were assigned as Control group. We compared pathologic features using univariable and multivariable logistic regression analysis between two groups. Results A total of 1,421 patients were included in the analysis. Patients’ age was 65.8 ± 6.7 years and prostate-specific antigen (PSA) was 12.8±16.1 ng/mL. Median and low 25 percentile of IIEF-5 were 14 and 8, respectively. Low Erectile Function group (IIEF-5<8) had higher risk to have high Gleason score (≥7(4+3), odds ratio (OR) 1.642, p<0.001) and large tumor volume (≥5 mL, OR 1.292, p=0.042). Even after adjusting age, year of surgery, body mass index, Charlson comorbidity index, PSA, clinical stage and biopsy Gleason score, Low Erectile Function group still had higher risk of high Gleason score (OR 1.910, p<0.001) and large tumor volume (OR 1.390, p=0.04) by multivariable logistic regressions. Conclusions Lower erectile function before RP was associated with higher Gleason’s score and larger tumor volume in final pathology. Thus, erectile function could be a surrogate barometer for prostate cancer aggressiveness.
publisher Sociedade Brasileira de Urologia
publishDate 2015
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000200265
work_keys_str_mv AT jeongchangwook preoperativeerectilefunctionandthepathologicfeaturesofprostatecancer
AT leesangchul preoperativeerectilefunctionandthepathologicfeaturesofprostatecancer
AT jeongseongjin preoperativeerectilefunctionandthepathologicfeaturesofprostatecancer
AT hongsungkyu preoperativeerectilefunctionandthepathologicfeaturesofprostatecancer
AT byunseoksoo preoperativeerectilefunctionandthepathologicfeaturesofprostatecancer
AT leesangeun preoperativeerectilefunctionandthepathologicfeaturesofprostatecancer
_version_ 1756428168534687744